Jin Medical International Ltd. (ZJYL)
USD 0.8
(9.59%)
USD 0.8
(9.59%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 19.82 Million USD | 3.29% |
| 2022 | 19.19 Million USD | -7.58% |
| 2021 | 20.76 Million USD | 28.22% |
| 2020 | 16.19 Million USD | -20.49% |
| 2019 | 20.36 Million USD | -2.61% |
| 2018 | 20.91 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 5.27 Million USD | -44.83% |
| 2024 Q2 | 5.27 Million USD | 0.0% |
| 2023 Q4 | 9.56 Million USD | 100.0% |
| 2023 FY | 19.82 Million USD | 3.29% |
| 2023 Q1 | 5.12 Million USD | 5.45% |
| 2023 Q2 | 10.25 Million USD | 100.0% |
| 2023 Q3 | 4.78 Million USD | -53.34% |
| 2022 Q4 | 4.86 Million USD | 0.0% |
| 2022 Q3 | 4.86 Million USD | 2.7% |
| 2022 Q2 | 4.73 Million USD | -0.0% |
| 2022 Q1 | 4.73 Million USD | -16.57% |
| 2022 FY | 19.19 Million USD | -7.58% |
| 2021 Q4 | 5.67 Million USD | 0.0% |
| 2021 FY | 20.76 Million USD | 28.22% |
| 2021 Q3 | 5.67 Million USD | 20.52% |
| 2021 Q2 | 4.7 Million USD | -0.0% |
| 2021 Q1 | 4.7 Million USD | 4.34% |
| 2020 Q4 | 4.51 Million USD | 0.0% |
| 2020 FY | 16.19 Million USD | -20.49% |
| 2020 Q1 | 3.58 Million USD | -29.6% |
| 2020 Q2 | 3.58 Million USD | -0.0% |
| 2020 Q3 | 4.51 Million USD | 25.86% |
| 2019 Q1 | 5.09 Million USD | 0.0% |
| 2019 Q4 | 5.09 Million USD | 0.0% |
| 2019 Q2 | 5.09 Million USD | 0.0% |
| 2019 Q3 | 5.09 Million USD | 0.02% |
| 2019 FY | 20.36 Million USD | -2.61% |
| 2018 FY | 20.91 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 79.488% |
| AngioDynamics, Inc. | 303.91 Million USD | 93.478% |
| AtriCure, Inc. | 399.24 Million USD | 95.035% |
| Avinger, Inc. | 7.65 Million USD | -159.036% |
| Azenta, Inc. | 665.07 Million USD | 97.02% |
| BioLife Solutions, Inc. | 143.27 Million USD | 86.165% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.448% |
| Daxor Corporation | 1.28 Million USD | -1447.929% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -8.438% |
| Femasys Inc. | 1.07 Million USD | -1749.068% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 82.342% |
| Hologic, Inc. | 4.03 Billion USD | 99.508% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.123% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.722% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 30.494% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 89.756% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1619.897% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1619.897% |
| Masimo Corporation | 2.04 Billion USD | 99.032% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 79.586% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 98.424% |
| Nephros, Inc. | 14.23 Million USD | -39.215% |
| NovoCure Limited | 509.33 Million USD | 96.108% |
| NEXGEL, Inc. | 4.08 Million USD | -384.751% |
| NEXGEL, Inc. | 4.08 Million USD | -384.751% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -580.916% |
| OraSure Technologies, Inc. | 405.47 Million USD | 95.112% |
| Pro-Dex, Inc. | 53.84 Million USD | 63.187% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -1013.507% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -3.754% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.339% |
| Repligen Corporation | 638.76 Million USD | 96.897% |
| Sanara MedTech Inc. | 64.98 Million USD | 69.501% |
| STAAR Surgical Company | 322.41 Million USD | 93.852% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 60.534% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.5% |